Form 4: Eli Lilly Director Acquires Shares Through Deferral Plan

Director Juan R. Luciano acquired 23 shares of Eli Lilly common stock through a deferral plan, to be settled after separation from service.

Summary

• On January 16, 2024, Juan R. Luciano, a director at Eli Lilly & Co, acquired 23 shares of common stock.
• The shares were acquired at a price of $634.57 per share.
• These shares were obtained through the Lilly Directors' Deferral Plan, in lieu of cash compensation.
• The shares will be settled in common stock after Mr. Luciano's separation from service.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed positively as it aligns director interests with shareholders. There is no indication of any negative sentiment.

Positives

• The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.

Future Outlook

The acquired shares will be settled in common stock following the reporting person's separation from service.

Industry Context

This is a routine filing related to director compensation and is common practice for publicly traded companies.

Comparison to Industry Standards

• Director share acquisitions are a common form of compensation in publicly listed companies.
• Many companies offer deferred compensation plans similar to the Lilly Directors' Deferral Plan.
• The specific details of these plans vary from company to company, but the general principle of aligning director interests with shareholder value is consistent.

Stakeholder Impact

• The acquisition of shares by a director can be seen positively by shareholders as it aligns the director's interests with the company's performance.

Key Dates

Keywords

Director Share Acquisition, Form 4, Lilly Directors' Deferral Plan, Stock Units, Insider Trading, Eli Lilly, LLY